S-23 is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc as a potential male hormonal contraceptive. It binds more strongly to the androgen receptor than older drugs such as andarine with a Ki of 1.7nM, and in animal studies showed a good ratio of anabolic to androgenic effects as well as dose-dependent suppression of spermatogenesis with spontaneous recovery after treatment discontinuation.
S-23 appears to be the most severe androgen receptor modulator to date.
S23 valuable lean body mass and bone mineral density. In a dose dependent way in an indirect way.
This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary use. Please use with our DISCLAIMER before ordering.
S-23 – Solution, 600mg (20mg/mL)
|Application||Selective Androgen Receptor Modulator|
|Molar Mass||416.753 g/mol|
|Synonyms||UNII-XDK89456WM, 3-(4-cyanophenoxy)-N-(4-cyano-3-trifluoromethylphenyl)-2-hydroxy-2-methylpropionamide, CCTH-methylpropionamide|
|Solubility||Soluble in PEG400, Ethanol|
|Organoleptic Profile||Clear liquid|
|Physical Form||Solution in PEG400|
|Terms||This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our disclaimer prior to ordering.|